Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Celemiab International Aktiebolag
AB
Active
Org 5564014735
Nordenskiöldsgatan 8, 211 19
Malmö
Educational support activities n.e.c.
· NACE 8569
Est. 1990
23 employees
Watchlist
Share
Sweden
/
Companies
/
Educational support activities n.e.c.
/
Celemiab International Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
13M
26M
39M
52M
16M
2020
25M
2021
27M
2022
37M
2023
45M
2024
EBITDA
SEK millions
0M
3M
5M
8M
10M
-4M
2020
6M
2021
1M
2022
7M
2023
9M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
15 944
25 377
26 745
37 433
45 255
Staff expenses
—
—
—
—
—
EBITDA
−4 162
5 625
800
7 146
9 312
Depreciation & amort.
−831
−1 020
−1 119
−1 428
−1 873
EBIT
−4 993
4 605
−319
5 718
7 439
Net financials
−165
−156
−141
5 999
4 952
Profit before tax
2 342
3 268
−460
8 668
7 198
Tax
−485
−678
−0
−498
−455
Net profit
1 857
2 590
−460
8 170
6 743
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
27 182
29 964
25 567
21 289
24 996
Equity
11 559
14 149
13 689
14 194
15 938
Long-term debt
3 167
1 667
667
0
0
Short-term debt
12 456
13 697
10 760
7 095
9 058
Total debt
15 623
15 364
11 427
7 095
9 058
Financial ratios
5-year trend
EBITDA margin
20.6%
This company
15.8%
Market median
+30% vs market
2020
2024
Equity ratio
63.8%
This company
38.2%
Market median
+67% vs market
2020
2024
Return on equity
42.3%
This company
18.4%
Market median
+130% vs market
2020
2024
Net profit margin
14.9%
This company
8.1%
Market median
+84% vs market
2020
2024
Asset turnover
1.81×
This company
1.12×
Market median
+62% vs market
2020
2024
Debt / equity
0.57×
This company
0.62×
Market median
+8% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Celemiab International Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
